ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,730Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 393

$431K Total Retail Price of All Prescriptions

Rank: 88 out of 393

647 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 647 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,066 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 450 408 1 1
LEVOTHYROXINE SODIUM 404 354 2 3
AMLODIPINE BESYLATE 384 377 3 4
LISINOPRIL 315 299 4 2
LOSARTAN POTASSIUM 309 297 5 12
LOVASTATIN 296 272 6 14
OMEPRAZOLE 294 270 7 6
HYDROCODONE-ACETAMINOPHEN 286 258 S3 8 5
METOPROLOL SUCCINATE 185 183 9 22
ZOLPIDEM TARTRATE 181 160 10 11
HYDROCHLOROTHIAZIDE 178 174 11 10
METOPROLOL TARTRATE 171 162 12 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 168 150 13 24
ATENOLOL 159 149 14 13
METFORMIN HCL 151 135 15 7
FLUTICASONE PROPIONATE 144 133 16 27
PRAVASTATIN SODIUM 136 132 17 18
LOSARTAN-HYDROCHLOROTHIAZIDE 129 126 18 31
FUROSEMIDE 125 125 19 8
METFORMIN HCL ER 111 102 20 63
TAMSULOSIN HCL 105 105 21 25
CITALOPRAM HBR 103 83 22 23
ALENDRONATE SODIUM 101 94 23 16
POTASSIUM CHLORIDE 98 93 24 20
BENAZEPRIL HCL 93 88 25 40
ATORVASTATIN CALCIUM 87 71 26 19
CLOPIDOGREL 84 84 27 33
SPIRIVA 79 78 28 41
TRIAMTERENE-HCTZ 78 78 29 49
ALLOPURINOL 75 75 30 26
AZITHROMYCIN 72 67 31 35
RANITIDINE HCL 71 63 32 29
WARFARIN SODIUM 70 70 33 17
GABAPENTIN 69 59 34 15
SERTRALINE HCL 62 55 35 28
FENOFIBRATE 57 53 36 43
CIPROFLOXACIN HCL 56 55 37 57
DONEPEZIL HCL 56 56 37 34
MELOXICAM 50 50 39 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.